Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2010
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2402278C Diabetic nutritionals
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition
11/11/2010WO2010129788A2 Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders
11/11/2010WO2010129752A1 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
11/11/2010WO2010129729A1 Substituted spirocyclic amines useful as antidiabetic compounds
11/11/2010WO2010129524A2 Plant medicinal compounds
11/11/2010WO2010129343A2 Method of reducing fat accumulation and inducing weight loss
11/11/2010WO2010129048A2 Therapeutic compounds
11/11/2010WO2010128788A2 Anti-obesity external dermal agent compositions containing capsaicin or capsaicin-like compounds as active ingredients
11/11/2010WO2010128425A1 Gpr 119 modulators
11/11/2010WO2010128414A1 Gpr 119 modulators
11/11/2010WO2010128401A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
11/11/2010WO2010128152A1 Fused heterocyclic c-glycosides for the treatment of diabetes
11/11/2010WO2010128061A1 Novel isoquinoline derivatives
11/11/2010WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010WO2010127470A1 Paeoniflorin preparations and uses thereof for fat reduction
11/11/2010WO2010108051A3 Inhibitors of diacylglycerol o-acyltransferase 1(dgat-1) and uses thereof
11/11/2010WO2010106542A3 USE OF NKp46 FOR PREVENTING DIABETES
11/11/2010WO2010094837A3 Sugar product
11/11/2010WO2010077074A3 Preparation for the treatment of diabetes comprising arginine thiazolidine carboxylate or a derivative thereof
11/11/2010WO2010054138A3 Modulators of atp-binding cassette transporters
11/11/2010WO2010042886A3 Pyrones for the treatment of metabolic disorders
11/11/2010WO2009135581A9 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/11/2010US20100287637 Methods of blocking tissue destruction by autoreactive t cells
11/11/2010US20100286284 5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphthalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde as medicaments
11/11/2010US20100286276 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof
11/11/2010US20100286275 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
11/11/2010US20100286269 Medium-Chain Length Fatty Acids and Glycerides as Nephroprotection Agents
11/11/2010US20100286267 Compounds for the treatment of metabolic disorders
11/11/2010US20100286255 Method for extracting secoisolariciresinol and dihydroquercetin from wood
11/11/2010US20100286247 Methods of Protection from Oxidative Stress
11/11/2010US20100286226 Combination therapy related to serotonin dual action compounds
11/11/2010US20100286225 Diazeniumdiolate compounds, a process for their preparation and pharmaceutical compositions containing them.
11/11/2010US20100286220 HNF4alpha ANTAGONISTS AND METHODS OF USE
11/11/2010US20100286210 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/11/2010US20100286206 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
11/11/2010US20100286203 Pharmaceutically acceptable salts of 2--2h-indazole-7-carboxamide
11/11/2010US20100286200 Combination of metformin and an mtp inhibitor
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010US20100286195 Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/11/2010US20100286184 Aqueous solution of conophylline and/or conophyllidine
11/11/2010US20100286172 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/2010US20100286171 Phenylacetamide derivative
11/11/2010US20100286168 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/2010US20100286161 Pyrazine derivatives and their use as potassium channel modulators
11/11/2010US20100286158 Dihydropyrimidinones
11/11/2010US20100286153 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/2010US20100286152 N-phenyl hydrazides as modulators of the ghrelin receptor
11/11/2010US20100286151 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders
11/11/2010US20100286149 Novel benzamide derivatives useful as potassium channel modulators
11/11/2010US20100286144 Heteroaryl derivatives
11/11/2010US20100286133 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/11/2010US20100286129 Novel benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/11/2010US20100286123 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286120 Pyridooxazepine derivative and use thereof
11/11/2010US20100286119 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
11/11/2010US20100286112 Compounds for the treatment of metabolic disorders
11/11/2010US20100286111 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/11/2010US20100286110 Azetidinyl g-protein coupled receptor agonists
11/11/2010US20100286105 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative
11/11/2010US20100286104 Agent for inhibiting visceral fat accumulation
11/11/2010US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses
11/11/2010US20100286095 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product
11/11/2010US20100286063 GNRH agonist combination drugs
11/11/2010US20100286060 Specific binding agents of human angiopoeitin-2
11/11/2010US20100286037 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase
11/11/2010US20100286036 Novel peptides that enhance tight junction permeability
11/11/2010US20100286035 Neuromedin u derivative
11/11/2010US20100286034 Uses for aqueous streams containing proteins
11/11/2010US20100286028 Use of a peptide as a therapeutic agent
11/11/2010US20100286025 Synthetic apolipoprotein e mimicking polypeptides and methods of use
11/11/2010US20100286024 Insulinotropic compounds and uses thereof
11/11/2010US20100285164 Orally Disintegrating Excipient
11/11/2010US20100285156 Composition for preventing and treating metabolic diseases comprising the extract of lysimachiae foenum-graeci herba
11/11/2010US20100285153 Lipolysis Stimulator
11/11/2010US20100285152 Composition for improving liver metabolism and diagnostic method
11/11/2010US20100285145 Gpr 119 modulators
11/11/2010US20100285143 Orally administerable solid pharmaceutical composition and a process thereof
11/11/2010US20100285131 Fgf21 mutants and uses thereof
11/11/2010US20100285126 Pharmaceutical compositions of fenofibrate
11/11/2010US20100285125 Delivery system for poorly soluble drugs
11/11/2010US20100285124 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological
11/11/2010US20100285117 Combination of triazine derivatives and insulin sensitisers
11/11/2010US20100285075 Novel Hemioxalate Salt of Eletriptan
11/11/2010US20100285009 Humanized anti-egfl7 antibodies and methods using same
11/11/2010US20100284987 Tablettable formulations of lipophilic health ingredients
11/11/2010US20100284972 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
11/11/2010US20100284946 Compressed Chewing Gum Comprising Sterol
11/11/2010US20100284925 Small Molecule Intervention for Obesity
11/11/2010CA2764232A1 Novel heterocyclic compounds
11/11/2010CA2760877A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
11/11/2010CA2760343A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010CA2760339A1 Novel isoquinoline derivatives
11/11/2010CA2759891A1 Gpr 119 modulators
11/11/2010CA2759671A1 Method of reducing fat accumulation and inducing weight loss
11/11/2010CA2759651A1 Substituted spirocyclic amines useful as antidiabetic compounds
11/11/2010CA2759078A1 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
11/11/2010CA2725972A1 Paeoniflorin preparations and uses thereof for fat reduction
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 1298